ArticleMedicine2020

A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPITER trial).

Kenta Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.